The Dutch consultancy firm Adryan specializes in the qualification and validation of pharmaceutical production facilities. For the past five years, it has had a branch at BioArk in Visp. The site manager, Robert Ziegler, explains the reasons for this location and at the same time describes how he perceives the development of the region and his company.
ten23health®, a leading Swiss contract development and manufacturing organization (CDMO), has released its 2024 Fairstainability Report, showcasing significant advancements in sustainable pharmaceutical manufacturing.
Listen to the interview with Virginia Franco, founder and CEO of Yoni Solutions, broadcast yesterday on Rhône FM. The Valais start-up, based on our BioArk Monthey technological park & supported by Fondation The Ark Incubator, is developing a pioneering technique to fight recurrent vaginal infections and is expanding internationally. An innovative approach to women’s health …
Yoni Solutions tackles a taboo subject: recurrent vaginal infections. Read More »
Winner of the Startup Pitch of the Ark Foundation last year, this Swiss biotechnology gem is taking off! Among the three companies to receive FIT support, alongside Carewell and Perivision, Bioscibex is also in the running for Venture Kick.
Dive into the groundbreaking work of Professor Franka Kalman, a leading figure in analytical chemistry and separation science. From her foundational contributions to HPLC and Capillary Electrophoresis to her innovative solutions for endotoxin detection, discover how her research at HES-SO Valais-Wallis is shaping the future of biopharmaceutical analysis and global health.
An opportunity for Swiss researchers! The prestigious L’Oréal-UNESCO For Women in Science Prize, supported by SATW, is being launched in Switzerland, offering financial support and recognition to female talent in STEM.
At the crossroads of science and sustainability, the Institute of Life Technologies at HES-SO Valais/Wallis is harnessing the untapped potential of microalgae. These microscopic organisms, often referred to as “green gold,” are proving to be a game-changer in biotechnology, offering solutions for renewable energy, environmental protection, and human health.
On the occasion of the International Day of Women and Girls in Science,which took place for the 10th edition on February 11th, this article highlights initiatives in Valais to encourage the presence of women in the life sciences: interactive workshops, mentoring programmes, the canton’s commitment to reducing inequalities and revealing female potential.
While the company is already well established in Switzerland and Europe, it is now setting out to conquer China, where its probiotics are already being marketed.
The “explosives” site at Gamsen in the Upper Valais produces more than just explosives. For more than four decades, the SSE Group has also been a successful player in the chemical and pharmaceutical sector through its Valsythese business unit. This sector has recently experienced strong growth within the Group. CEO Max Lauwiner talks to us …
Sion Site
Rue de l’Industrie 23
CH-1950 Sion
Tél. +41 (0) 58 332 21 20
info@bioark.ch
Monthey Site
Rte de l’Ile-au-bois 1A
CH-1870 Monthey
Tél. +41 (0) 58 332 21 20
info@bioark.ch
Massimo Nobile
| BioArk | Book a meeting room
